Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers

CONCLUSION: Tumor-agnostic carrier-cocktails significantly enhance the therapeutic efficacy of existing alpha-particle radionuclide-antibody treatments.PMID:38641714 | DOI:10.1007/s00259-024-06710-0
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research